FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3045698175> ?p ?o ?g. }

• W3045698175 endingPage "104515" @default.
• W3045698175 startingPage "104515" @default.
• W3045698175 abstract "Majority of non-small cell lung cancer (NSCLC) patients progressed on epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) due to acquired T790M mutation. Blood sample is increasingly used in clinical setting for EGFR T790M detection and our laboratory employed the droplet digital PCR (ddPCR) methodology for testing. This study investigated the positive rate, specimen type for rebiopsy and clinical impact of blood-based EGFR T790M testing.We retrospectively evaluated clinical samples that underwent plasma EGFR T790M testing in TTSH Molecular Diagnostic Laboratory from August 2017 to September 2019. Data on diagnosis, EGFR activating and T790M mutations, and treatment strategies were recorded.A total of 104 progressive NSCLC cases were included in this study. Overall, 46 patients (44.2%) were tested T790M positive, and 47.8% of these tested positive had low levels (defined as ≤3% fractional abundance and <50 copies/mL plasma), which may be missed by the conventional methods with lower sensitivity. Of these tested with low T790M abundance, 77.3% subsequently received osimertinib. Activating mutations were not detected in 42 (40.4%) cases, indicating that the tumors were not actively shedding ctDNA. Among these, 24 patients underwent repeat testing with tissue or blood specimens. Thirteen patients were subsequently tested T790M positive and 12 of them switched treatment to osimertinib. The recommendation to repeat testing with a different biopsy or after a suitable interval increased the overall positive rate to 56.7% (59/104).The use of a highly sensitive platform such as ddPCR for the detection of low abundance T790M, and the approach of repeat testing in cases with insufficient ctDNA increased the positive rate. This in turn identified more patients who are eligible for targeted therapy." @default.
• W3045698175 created "2020-08-03" @default.
• W3045698175 creator A5034697984 @default.
• W3045698175 creator A5055838593 @default.
• W3045698175 creator A5073751521 @default.
• W3045698175 date "2020-10-01" @default.
• W3045698175 modified "2023-10-01" @default.
• W3045698175 title "Clinical implementation of plasma EGFR T790M testing using droplet digital PCR in TKI-resistant NSCLC patients" @default.
• W3045698175 cites W1990013637 @default.
• W3045698175 cites W2007528734 @default.
• W3045698175 cites W2027735722 @default.
• W3045698175 cites W2075445339 @default.
• W3045698175 cites W2097560495 @default.
• W3045698175 cites W2101569260 @default.
• W3045698175 cites W2138089710 @default.
• W3045698175 cites W2153733592 @default.
• W3045698175 cites W2154149901 @default.
• W3045698175 cites W2163351155 @default.
• W3045698175 cites W2171237493 @default.
• W3045698175 cites W2254875607 @default.
• W3045698175 cites W2535355244 @default.
• W3045698175 cites W2549005776 @default.
• W3045698175 cites W2560717039 @default.
• W3045698175 cites W2591118779 @default.
• W3045698175 cites W2618435741 @default.
• W3045698175 cites W2732121391 @default.
• W3045698175 cites W2770828094 @default.
• W3045698175 cites W2790465248 @default.
• W3045698175 cites W2790649727 @default.
• W3045698175 cites W2790958665 @default.
• W3045698175 cites W2800477471 @default.
• W3045698175 cites W2803026631 @default.
• W3045698175 cites W2885264750 @default.
• W3045698175 cites W2892005049 @default.
• W3045698175 cites W2919469015 @default.
• W3045698175 cites W2947050938 @default.
• W3045698175 cites W2961956354 @default.
• W3045698175 cites W2963672195 @default.
• W3045698175 doi "https://doi.org/10.1016/j.yexmp.2020.104515" @default.
• W3045698175 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32738312" @default.
• W3045698175 hasPublicationYear "2020" @default.
• W3045698175 type Work @default.
• W3045698175 sameAs 3045698175 @default.
• W3045698175 citedByCount "9" @default.
• W3045698175 countsByYear W30456981752021 @default.
• W3045698175 countsByYear W30456981752022 @default.
• W3045698175 countsByYear W30456981752023 @default.
• W3045698175 crossrefType "journal-article" @default.
• W3045698175 hasAuthorship W3045698175A5034697984 @default.
• W3045698175 hasAuthorship W3045698175A5055838593 @default.
• W3045698175 hasAuthorship W3045698175A5073751521 @default.
• W3045698175 hasConcept C104317684 @default.
• W3045698175 hasConcept C121608353 @default.
• W3045698175 hasConcept C126322002 @default.
• W3045698175 hasConcept C142724271 @default.
• W3045698175 hasConcept C143998085 @default.
• W3045698175 hasConcept C2775934546 @default.
• W3045698175 hasConcept C2776256026 @default.
• W3045698175 hasConcept C2777626846 @default.
• W3045698175 hasConcept C2777930144 @default.
• W3045698175 hasConcept C2778087573 @default.
• W3045698175 hasConcept C2779438470 @default.
• W3045698175 hasConcept C2779529041 @default.
• W3045698175 hasConcept C2780580887 @default.
• W3045698175 hasConcept C48126324 @default.
• W3045698175 hasConcept C49105822 @default.
• W3045698175 hasConcept C55493867 @default.
• W3045698175 hasConcept C71924100 @default.
• W3045698175 hasConcept C86803240 @default.
• W3045698175 hasConceptScore W3045698175C104317684 @default.
• W3045698175 hasConceptScore W3045698175C121608353 @default.
• W3045698175 hasConceptScore W3045698175C126322002 @default.
• W3045698175 hasConceptScore W3045698175C142724271 @default.
• W3045698175 hasConceptScore W3045698175C143998085 @default.
• W3045698175 hasConceptScore W3045698175C2775934546 @default.
• W3045698175 hasConceptScore W3045698175C2776256026 @default.
• W3045698175 hasConceptScore W3045698175C2777626846 @default.
• W3045698175 hasConceptScore W3045698175C2777930144 @default.
• W3045698175 hasConceptScore W3045698175C2778087573 @default.
• W3045698175 hasConceptScore W3045698175C2779438470 @default.
• W3045698175 hasConceptScore W3045698175C2779529041 @default.
• W3045698175 hasConceptScore W3045698175C2780580887 @default.
• W3045698175 hasConceptScore W3045698175C48126324 @default.
• W3045698175 hasConceptScore W3045698175C49105822 @default.
• W3045698175 hasConceptScore W3045698175C55493867 @default.
• W3045698175 hasConceptScore W3045698175C71924100 @default.
• W3045698175 hasConceptScore W3045698175C86803240 @default.
• W3045698175 hasLocation W30456981751 @default.
• W3045698175 hasLocation W30456981752 @default.
• W3045698175 hasOpenAccess W3045698175 @default.
• W3045698175 hasPrimaryLocation W30456981751 @default.
• W3045698175 hasRelatedWork W2765184747 @default.
• W3045698175 hasRelatedWork W2767471949 @default.
• W3045698175 hasRelatedWork W2767888602 @default.
• W3045698175 hasRelatedWork W2767944749 @default.
• W3045698175 hasRelatedWork W2777429645 @default.
• W3045698175 hasRelatedWork W2887887720 @default.
• W3045698175 hasRelatedWork W2921871143 @default.

• next